VRL Maryland LLC

VRL Maryland LLC, a self-certified small disadvantaged business based in Rockville, Maryland, provides laboratory animal diagnostic testing and sentinel biological sample testing services to federal biomedical research institutions and the Department of Veterans Affairs as a prime contractor operating exclusively in full-and-open and Total Small Business set-aside vehicles (no subcontractor role). The company specializes in polymerase chain reaction (PCR) testing, pathogen analysis, and animal health monitoring for research facilities, with work performed across Montgomery Village and Bethesda, Maryland, Durham and Research Triangle Park, North Carolina, San Francisco, and Fort Detrick.

VRL Maryland's customer base concentrates heavily in federal research infrastructure. The National Institute of Environmental Health Sciences leads by potential value (11 awards, $4.5 million combined ceiling), followed by the Uniformed Services University of the Health Sciences by award count (15 awards, $969 thousand), the Defense Health Agency (2 awards, $851 thousand), and the Department of Veterans Affairs Veterans Integrated Service Network 21 (5 awards, $397 thousand). Together these four agencies account for 89% of recent awards. The dollar concentration differs markedly from volume — NIEHS's research contracts dominate combined potential value at roughly 64% of the portfolio, while USUHS places many smaller quarterly delivery orders against a standing IDC.

VRL Maryland holds five active Indefinite Delivery Contracts as a prime. The highest-ceiling IDC is with NIEHS ($1.83 million, through July 2029), which underwrites laboratory animal diagnostic testing across its biomedical research programs. The Defense Health Agency awarded a Total Small Business single-award IDC ($600,921 ceiling through September 2030) for comprehensive animal health testing at the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick, with approximately 120 sample submissions monthly across serology, PCR, microbiology, parasitology, necropsy, histopathology, and environmental testing. The Uniformed Services University of the Health Sciences holds a $714,226.97 IDC (through December 2027) executed through quarterly purchase-card delivery orders averaging $13,000 per quarter. The Veterans Affairs Veterans Integrated Service Network 21 operates a $176,963.50 Total Small Business IDC (through June 2029) for sentinel biological sample testing at the San Francisco VA Medical Center. VRL Maryland also manages delivery orders against five additional parent vehicles, including a BPA with HHS and legacy NIEHS requirements contracts.

Recent activity shows modest growth from two awards in 2023 to seven in both 2024 and 2025, with only one award recorded in the first half of 2026. The portfolio carries minimal recompete exposure — only one award (potential value $35 thousand) completes within the next twenty-four months. Combined potential value across 38 prime awards totals $7 million, though only $620 thousand has been obligated to date (9% utilization rate), reflecting the structure of indefinite-delivery vehicles with modest task-order exercise to date. VRL Maryland's NAICS concentration sits entirely in Testing Laboratories and Services (32 of 38 awards), with PSC codes split between Reference Laboratory Testing (20 awards) and Special Studies/Analysis — Chemical/Biological (12 awards). The company competes in full-and-open federal research procurement, with no presence in full-and-open civilian agency work outside health and research domains.

VRL testing is extensive and capable of defining a wide variety of infectious and autoimmune diseases. Of greatest importance is the availability of panel testing. Recognizing that disease control is dependent upon an awareness of infectious changes within the primate colony, a number of viral antigens are recommended as a panel in order to provide an etiologic marker of colony status at any period in time. Obviously, the occurrence of catastrophic disease outbreaks demands rapid and intensive involvement by all concerned parties. VRL offers our full laboratory resources for the ultimate elimination of any offending etiologic agent.